Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Litigation: Janssen Vs. Samsung Anticipates Supreme Court Decision

May 21 2017

• By Brenda Sandburg

court house

Related Content

FDA's Worst Case Scenario: Supreme Court Might Defer To It On Biosimilars

Apr 27 2017

Samsung’s Renflexis: Second US Biosimilar To Janssen’s Remicade, With A Few Firsts

Apr 22 2017

Biosimilar Litigation: Genentech Avastin Suit Tossed; Janssen Remicade Case Uncertain

Mar 03 2017

Pfizer Eliminates Roadblock To Remicade Biosimilar Launch

Aug 17 2016

Related Companies

Johnson & Johnson

Samsung Bioepis Co., Ltd.

Amgen, Inc.

Novartis AG

Celltrion, Inc.

Pfizer Inc.

Additional Topics

United States Biosimilars Legal Issues Intellectual Property Policy BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window